Trial Profile
Monitoring of treatment with bevacizumab in patients with metastatic colorectal cancer: a single centre observational study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Aug 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Antineoplastics
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 31 Dec 2012 Status changed from recruiting to completed as reported by ISRCTN.
- 06 Oct 2010 New trial record